Eli Lilly Surpasses Expectations: Blockbuster Drugs Drive $3 Billion Revenue Hike in 2024 Outlook
Mounjaro and Zepbound Fuel Eli Lilly’s Strong Second Quarter, Propelling Stock Surge and Revised Annual Forecasts Eli Lilly & Co. ...
Mounjaro and Zepbound Fuel Eli Lilly’s Strong Second Quarter, Propelling Stock Surge and Revised Annual Forecasts Eli Lilly & Co. ...
Q2 Financial Performance: A Mixed Bag Rivian Automotive (RIVN) faced a significant setback in premarket trading on Wednesday, with its ...
Revenue and User Metrics Show Over 50% Year-Over-Year Increase Reddit (RDDT), one of the most popular online communities, announced its ...
AI Demand Propels Revenue Surge; Stock Split Announced for October Super Micro Computer (SMCI), a leading provider of comprehensive IT ...
Robust Growth in Revenues and Customer Base Underscores Palantir’s Expanding Influence in AI Revolution Palantir Technologies (PLTR) recently announced its ...
Expansion in Malaysia, New Collaborations, and Financial Performance Highlight the Quarter Enovix Corporation (ENVX), a global leader in high-performance battery ...
Record Revenues and Exceptional Growth Mark Milestones in Diversification Strategy Qualcomm Incorporated (QCOM) has announced robust financial results for its ...
Revenue growth and AI advancements position AMD for a promising second half of the year Advanced Micro Devices (AMD) has ...
Despite Revenue Dip, Strong Membership Growth and Strategic Actions Signal a Resilient Future Starbucks Corporation (SBUX) announced its financial results ...
Despite Challenges, PayPal Leverages Operational Efficiency to Project Strong Growth PayPal (PYPL) has once again raised its forecast for full-year ...
© 2024 All Rights Reserved: STOXPO.
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information
Do you really wish to opt-out?